Erratum to: HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia

Errata

This article corrects:

  1. HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia Volume 32, Issue 1, 231–243, Article first published online: 3 January 2014

No abstract is available for this article.

Ancillary